SA

Shilphy Albert

Active Director Designated Partner DIN 09766663
DIN 09766663 First appointment Oct 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shilphy Albert

Data last updated:

Shilphy Albert is a Designated Partner at Azova Pharmaceuticals Llp (since 2022). The company operates in Business Services.

DIN 09766663
Primary Designation Designated Partner
Industry Business Services
First Appointment 22 Oct 2022
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Oct 20222020Active

Board colleagues of Shilphy Albert

NameDINCompanyDesignation
Murikkumthara Dominic Albert08946728Azova Pharmaceuticals LlpDesignated Partner
Sugathan Akhil08946729Azova Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Azova Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Shilphy Albert

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shilphy Albert

Shilphy Albert currently holds 1 directorship: Azova Pharmaceuticals Llp (Designated Partner, since 22 Oct 2022).

Shilphy Albert was first appointed on 22 Oct 2022 as Designated Partner at Azova Pharmaceuticals Llp.

The current boards of Shilphy Albert's companies include Murikkumthara Dominic Albert (Azova Pharmaceuticals Llp), Sugathan Akhil (Azova Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available